GlassScriptPhysician profile
Karen A Tormoehlen
NPI 1174843262
$4,015.07
in general payments reported to CMS, 2019-2025
30 companies · $821 in 2025
The $821 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.42 · 2022: $1,572 · 2023: $633 · 2024: $897 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,351.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $462.54 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $286.67 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $265.96 | 2023-2025 | |
| Indivior INC. | $256.70 | 2022-2025 | Sublocade, Perseris |
| Inspire Medical Systems, INC. | $193.43 | 2023-2024 | Inspire |
| Acadia Pharmaceuticals INC | $188.22 | 2022 | |
| Sk Life Science, INC. | $181.27 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.39 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $144.59 | 2022 | |
| Neurocrine Biosciences, INC. | $139.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $128.49 | 2022-2025 | Spravato |
| Emd Serono, INC. | $124.99 | 2023 | |
| Eisai INC. | $124.94 | 2024 | |
| Horizon Therapeutics Plc | $123.42 | 2022 | |
| Vanda Pharmaceuticals INC. | $122.42 | 2025 | Ponvory |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $116.12 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sage Therapeutics, LLC | $111.91 | 2024 | |
| Alkermes, INC. | $106.26 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Impel Pharmaceuticals INC. | $98.08 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $86.37 | 2025 | Cobenfy |
| Amgen INC. | $84.81 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $78.92 | 2022 | |
| Neurelis, INC. | $77.75 | 2024 | Valtoco |
| Gilead Sciences, INC. | $76.91 | 2023 | Epclusa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.14 | 2024-2025 | Caplyta |
| Harmony Biosciences LLC | $63.54 | 2022 | |
| Amneal Pharmaceuticals LLC | $51.86 | 2022 | |
| Silk Road Medical, INC. | $37.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Biohaven Pharmaceuticals, INC. | $33.17 | 2021 | |
| Lundbeck LLC | $19.60 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Tormoehlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.